Qiagen N.V.
QIAGEN N.V.: Release of a capital market information
QIAGEN N.V.
/ Share Repurchase
Disclosure according to Article 5 Section (1) and (6) of the EU Regulation 596/2014 in conjunction with Article 2 Section (2) and (3) of the Delegated EU Regulation 2016/1052 / Share Repurchase – Interim Reporting With disclosure dated September 22, 2021, QIAGEN N.V. announced pursuant to Article 5 Section (1) and (6) of the EU Regulation no 596/2014 and Article 2 Section (1) of the Delegated EU Regulation no 2016/1052 the beginning of a second tranche of up to USD 19.4 million starting on September 27, 2021 under the share repurchase program originally announced on July 12, 2021. The number of shares which have been bought back within the framework of such tranche of the share repurchase program in the time period from October 11, 2021 until and including October 15, 2021, amounts to 96,894 shares. Shares were bought back as follows:
The underlying individual trades are published on the website of QIAGEN N.V. (https://corporate.qiagen.com/investor-relations/stock-information/share-buyback/default.aspx). The total number of shares which have already been bought back within the framework of such tranche of the share repurchase program from September 27, 2021 until and including October 15, 2021 amounts to 318,557 shares. The purchase of the shares of QIAGEN N.V. was carried out by a financial institution that has been commissioned by QIAGEN N.V. Venlo, 19 October 2021 Managing Board ### QIAGEN
19.10.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | QIAGEN N.V. |
Hulsterweg 82 | |
5912 PL Venlo | |
Netherlands | |
Internet: | www.qiagen.com |
End of News | DGAP News Service |